Carrier‐Free Biomimetic Organic Nanoparticles with Super‐High Drug Loading for Targeted NIR‐II Excitable Triple‐Modal Bioimaging and Phototheranostics
Small · 2024-12 · 20 (52)
DOI: 10.1002/smll.202406003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 18.10.2024. Verfasst von Ying Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Theranostic Nanomedicine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Suzhou Science and Technology Program.
Abstract (Originalsprache)
Multimodal near‐infrared II (NIR‐II) theranostics combined with nanotechnology have emerged as promising treatments for cancer due to their noninvasive and high spatiotemporal nature. Traditional NIR‐II theranostics typically comprise useless and massive inert carriers, resulting in low drug loading capacity, reduced therapeutic effects, and potential biotoxicity. To overcome these limitations, this work reports carrier‐free NIR‐II theranostics simultaneously with high drug loading capacity and multimodal NIR‐II imaging capabilities for cancer phototheranostics in the NIR‐II window. Carrier‐free BTA nanoparticles (NPs) are prepared by self‐assembling the NIR‐II responsive conjugated oligomer BTA without adding coating agents; these NPs exhibited 100% drug loading and high‐performance NIR‐II theranostic capabilities. Cancer cell membranes are camouflaged on carrier‐free BTA NPs to provide homologous targeting ability, enhanced stability, and 77.8% drug loading. Both in vitro and in vivo studies have indicated that biomimetic NPs provide efficient triple‐modal guidance for NIR‐II fluorescence, photoacoustic, and photothermal imaging and complete tumor elimination via photothermal therapy (PTT). Additionally, theranostics‐based treatments with good biosecurity are demonstrated. This study contributes a new strategy for the design of high‐drug‐loading NIR‐II theranostics and further promotes the clinical translation of theranostic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, P. R. China.
ORCID-Profile: Shengliang Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Suzhou Science and Technology Program
- Jiangsu Specially Appointed Professorship,
- Leading Talents of Innovation and Entrepreneurship of Gusu
- Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions
- Suzhou International Joint Laboratory for Diagnosis and Treatment of Brain Diseases
Zitieren
APA
Liu, Y., Luo, Y., Gao, Y., Ma, Y., Huang, Z., Yang, Y., Li, X., & Li, S. (2024). Carrier‐Free Biomimetic Organic Nanoparticles with Super‐High Drug Loading for Targeted NIR‐II Excitable Triple‐Modal Bioimaging and Phototheranostics. Small, 20(52). https://doi.org/10.1002/smll.202406003
Vancouver
Liu Y, Luo Y, Gao Y, Ma Y, Huang Z, Yang Y, et al. Carrier‐Free Biomimetic Organic Nanoparticles with Super‐High Drug Loading for Targeted NIR‐II Excitable Triple‐Modal Bioimaging and Phototheranostics. Small. 2024;20(52). doi:10.1002/smll.202406003
BibTeX
@article{Liu2024,
author = {Liu, Ying and Luo, Yu and Gao, Yijian and Ma, Yujie and Huang, Zhongming and Yang, Yuliang and Li, Xiliang and Li, Shengliang},
title = {Carrier‐Free Biomimetic Organic Nanoparticles with Super‐High Drug Loading for Targeted NIR‐II Excitable Triple‐Modal Bioimaging and Phototheranostics},
journal = {Small},
year = {2024},
volume = {20},
number = {52},
doi = {10.1002/smll.202406003}
}
EUVIMED